|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2013-05-10 Sale |
2013-05-13 6:46 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 4,000 | $26.66 | $106,640 | 12,829 (Direct) | View |
| 2013-01-23 Purchase | 2013-01-25 5:17 pm |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC INVESTMENT 10 LLC (10% owner) | 39,600 | $19.78 | $783,181 | 2,163,412 (Indirect) |
View |
| 2012-12-14 Purchase | 2012-12-18 4:36 pm |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (10% owner) | 5,386 | $18.63 | $100,365 | 2,123,812 (Indirect) |
View |
| 2012-12-06 Purchase |
2012-12-10 4:40 pm | LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (10% owner) | 50,100 | $17.94 | $898,959 | 2,118,426 (Indirect) |
View |
| 2012-12-05 Purchase |
2012-12-05 4:53 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 370 | $17.99 | $6,656 | 37,870 (Direct) |
View |
| 2012-12-05 Purchase | 2012-12-05 4:53 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 2,000 | $18.03 | $36,060 | 112,025 (Direct) | View |
| 2012-11-29- -2012-11-30 Sale |
2012-12-03 2:13 pm | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 20,000 | $19.9 | $398,071 | 211,396 (Indirect) | View |
| 2012-11-27- -2012-11-28 Sale | 2012-11-29 3:04 pm | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 100,000 | $19.54 | $1,953,600 | 231,396 (Indirect) |
View |
| 2012-10-26- -2012-10-31 Purchase(A) | 2012-11-19 5:24 pm |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (10% owner) | 16,591 | $15.19 | $252,022 | 741,627 (Indirect) | View |
| 2012-08-29 Purchase |
2012-11-15 6:11 pm |
LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 2,743 | $16.36 | $44,875 | 2,743 (Indirect) |
View |
| 2012-10-26- -2012-10-31 Purchase |
2012-11-02 6:36 pm |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N (10% owner) | 16,591 | $15.19 | $252,022 | 741,627 (Indirect) |
View |
| 2012-09-07 Sale |
2012-09-10 1:55 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 4,249 | $18.77 | $79,754 | 14,329 (Direct) |
View |
| 2012-08-13 Purchase |
2012-08-14 7:19 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 500 | $16.39 | $8,195 | 110,025 (Direct) | View |
| 2012-06-01 Purchase | 2012-06-05 12:56 pm |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason (Director) | 700 | $11.98 | $8,386 | 285,036 (Indirect) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount | Shares Ownership |
Filing |
| 2013-06-11 Option Award | 2013-06-13 07:58 am |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L (Director) | 3,621 | $0 | $0 | 21,046 (Direct) | View |
| 2013-06-11 Option Award | 2013-06-13 07:55 am | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 4,318 | $0 | $0 | 63,743 (Direct) | View |
| 2013-06-11 Option Award | 2013-06-12 5:13 pm |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil (Director) | 4,318 | $0 | $0 | 40,540 (Direct) |
View |
| 2013-06-11 Option Award | 2013-06-12 5:12 pm | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L (Director) | 3,621 | $0 | $0 | 25,156 (Direct) |
View |
| 2013-06-11 Option Award | 2013-06-12 5:12 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W (Director) | 4,318 | $0 | $0 | 41,266 (Direct) | View |
| 2013-06-11 Option Award |
2013-06-12 5:11 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C (Director) | 4,318 | $0 | $0 | 40,036 (Direct) | View |
| 2013-06-11 Option Award | 2013-06-12 5:11 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason (Director) | 2,925 | $0 | $0 | 31,243 (Direct) | View |
| 2013-06-03 Option Award | 2013-06-04 8:03 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 12,000 | $0 | $0 | 120,025 (Direct) | View |
| 2012-02-09 Option Award(A) |
2013-06-04 8:03 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 6,000 | $0 | $0 | 95,275 (Direct) |
View |
| 2013-06-03 Option Award |
2013-06-04 8:02 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 8,333 | $0 | $0 | 43,870 (Direct) | View |
| 2011-04-18 Option Award(A) | 2013-06-04 8:02 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 16,667 | $0 | $0 | 16,667 (Direct) |
View |
| 2013-02-15 Option Award |
2013-02-19 3:43 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 2,500 | $0 | $0 | 16,829 (Direct) | View |
| 2013-02-15 Option Award | 2013-02-19 3:42 pm |
LIGAND PHARMACEUTICALS INC | LGND | DeSilva Nishan M (VP, Corporate Development) | 5,000 | $0 | $0 | 15,490 (Direct) |
View |
| 2013-02-15 Option Award |
2013-02-19 3:42 pm | LIGAND PHARMACEUTICALS INC | LGND | Sharp John P (VP Finance and CFO) | 2,500 | $0 | $0 | 24,166 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 6,000 | $0 | $0 | 43,870 (Direct) | View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 8,000 | $0 | $0 | 120,025 (Direct) | View |
| 2012-12-31 Other | 2013-01-03 8:27 pm |
LIGAND PHARMACEUTICALS INC | LGND | DeSilva Nishan M (VP, Corporate Development) | 490 | $14.54 | $7,122 | 10,490 (Direct) |
View |
| 2012-12-21 Exercise | 2012-12-21 5:51 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W (Director) | 3,333 | $12.06 | $40,196 | 36,948 (Direct) | View |
| 2012-08-31 Other | 2012-09-05 09:07 am | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 41,583 | $0 | $0 | 0 (Indirect) | View |
| 2012-06-29 Other |
2012-07-03 5:47 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 1,250 | $10.12 | $12,654 | 109,525 (Direct) | View |
| 2012-06-29 Other | 2012-07-03 5:46 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 1,250 | $10.12 | $12,654 | 37,500 (Direct) | View |
| 2012-06-29 Other |
2012-07-03 5:46 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 1,250 | $10.12 | $12,654 | 18,578 (Direct) |
View |
| 2012-05-31- -2012-06-01 Option Award | 2012-06-04 8:28 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L (Director) | 6,721 | $3.577 | $24,040 | 17,425 (Direct) |
View |
| 2012-05-31 Option Award |
2012-06-04 8:28 pm |
LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 4,721 | $0 | $0 | 59,425 (Direct) |
View |
| 2012-05-31 Option Award |
2012-05-31 7:41 pm |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason (Director) | 6,517 | $0 | $0 | 28,318 (Direct) | View |
| 2012-02-09 Option Award | 2012-02-13 2:17 pm | LIGAND PHARMACEUTICALS INC | LGNDD | Kazmi Syed (VP, Bus. Dev. & Strategic Plan) | 4,000 | $0 | $0 | 18,230 (Direct) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2013-06-11 Option Award | 2013-06-13 07:58 am | N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L (Director) | 7,335 | $32.3 | 7,335 (Direct) |
View |
| 2013-06-11 Option Award | 2013-06-13 07:55 am |
N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 7,335 | $32.3 | 7,335 (Direct) | View |
| 2013-06-11 Option Award | 2013-06-12 5:13 pm | N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil (Director) | 7,335 | $32.3 | 7,335 (Direct) |
View |
| 2013-06-11 Option Award |
2013-06-12 5:12 pm |
N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L (Director) | 7,335 | $32.3 | 7,335 (Direct) | View |
| 2013-06-11 Option Award | 2013-06-12 5:12 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W (Director) | 7,335 | $32.3 | 7,335 (Direct) | View |
| 2013-06-11 Option Award |
2013-06-12 5:11 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C (Director) | 7,335 | $32.3 | 7,335 (Direct) |
View |
| 2013-06-11 Option Award |
2013-06-12 5:11 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason (Director) | 7,335 | $32.3 | 7,335 (Direct) |
View |
| 2013-06-03 Option Award |
2013-06-04 8:03 pm |
N/A 2023-06-03 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 14,334 | $32 | 14,334 (Direct) | View |
| 2012-02-09 Option Award | 2013-06-04 8:03 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 160,666 | $14.47 | 160,666 (Direct) |
View |
| 2011-04-18 Option Award |
2013-06-04 8:02 pm |
N/A 2021-04-18 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 51,546 | $9.97 | 51,546 (Direct) |
View |
| 2013-02-15 Option Award |
2013-02-19 3:43 pm |
N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 4,856 | $21.92 | 4,856 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:43 pm |
N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S (VP, Gen. Counsel & Secretary) | 15,144 | $21.92 | 15,144 (Direct) | View |
| 2013-02-15 Option Award |
2013-02-19 3:42 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | DeSilva Nishan M (VP, Corporate Development) | 4,374 | $21.92 | 4,374 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:42 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | DeSilva Nishan M (VP, Corporate Development) | 40,626 | $21.92 | 40,626 (Direct) |
View |
| 2013-02-15 Option Award |
2013-02-19 3:42 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | Sharp John P (VP Finance and CFO) | 4,432 | $21.92 | 4,432 (Direct) | View |
| 2013-02-15 Option Award |
2013-02-19 3:42 pm |
N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | Sharp John P (VP Finance and CFO) | 15,568 | $21.92 | 15,568 (Direct) | View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm | N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 8,375 | $21.92 | 8,375 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm | N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W (EVP and COO) | 64,625 | $21.92 | 64,625 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 11,384 | $21.92 | 11,384 (Direct) |
View |
| 2013-02-15 Option Award | 2013-02-19 3:41 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L (President & CEO Director) | 95,616 | $21.92 | 95,616 (Direct) | View |
| 2012-05-31 Option Award | 2012-06-04 8:28 pm | N/A 2022-05-31 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L (Director) | 7,335 | $12.53 | 7,335 (Direct) |
View |
| 2012-05-31 Option Award |
2012-06-04 8:28 pm |
N/A 2022-05-31 | LIGAND PHARMACEUTICALS INC | LGND | KNOTT DAVID M (Director) | 7,335 | $12.53 | 7,335 (Direct) |
View |
| 2012-05-31 Option Award |
2012-05-31 7:41 pm | N/A 2022-05-31 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason (Director) | 7,335 | $12.53 | 7,335 (Direct) |
View |
| 2012-02-09 Option Award |
2012-02-13 2:17 pm |
N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGNDD | Kazmi Syed (VP, Bus. Dev. & Strategic Plan) | 16,866 | $14.47 | 16,866 (Direct) | View |
| 2012-02-09 Option Award |
2012-02-13 2:17 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGNDD | Kazmi Syed (VP, Bus. Dev. & Strategic Plan) | 8,134 | $14.47 | 8,134 (Direct) |
View |
|
© 2005-2013 SecForm4.Com All rights reserved. Archives: 2013 2012 2011 2010 2009 2008 ... Wed, 19 Jun 2013 03:12:55 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |